The effect of lowering dose of rituximab on the neuromyelitis optica spectrum disorder relapse rate during COVID-19 epidemic period

(2023) The effect of lowering dose of rituximab on the neuromyelitis optica spectrum disorder relapse rate during COVID-19 epidemic period. Journal of the Neurological Sciences. p. 1. ISSN 0022-510X

Full text not available from this repository.

Item Type: Article
Keywords: Neurosciences & Neurology
Page Range: p. 1
Journal or Publication Title: Journal of the Neurological Sciences
Journal Index: ISI
Volume: 455
Identification Number: https://doi.org/10.1016/j.jns.2023.121866
ISSN: 0022-510X
Depositing User: خانم ناهید ضیائی
URI: http://eprints.mui.ac.ir/id/eprint/26609

Actions (login required)

View Item View Item